Dr. Michael Morris on Combining and Sequencing Radium-223

Partner | Cancer Centers | <b>Memorial Sloan Kettering Cancer Center </b>

Michael Morris, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses combining radium-223 with other types of treatment and how to best optimize the use of the drug alone.

Michael Morris, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses combining radium-223 with other types of treatment and how to best optimize the use of the drug alone.

Androgen receptor—directed therapy, chemotherapy, and novel therapeutics could also be combined with radium-223 to improve survival, says Morris. There is currently a study looking at radium-223 and abiraterone.

Work is also still being done to better understand how to administer radium-223 alone, says Morris. Questions still remain regarding how frequently patients should receive radium-223, how long they should take the drug, and at what dose.